Cardioverter Defibrillator Devices Market - Global Opportunity Analysis and Industry Forecast (2017-2022)
|発行||Meticulous Market Research Pvt. Ltd.||商品コード||600666|
|出版日||ページ情報||英文 195 Pages
|世界の心臓除細動器市場：機会分析と産業予測 Cardioverter Defibrillator Devices Market - Global Opportunity Analysis and Industry Forecast (2017-2022)|
|出版日: 2018年01月23日||ページ情報: 英文 195 Pages||
Cardioverter Defibrillator Devices Market Size by Product Type [Implantable Cardioverter Defibrillator (Transvenous Cardioverter Defibrillator, Subcutaneous Cardioverter Defibrillator), External Cardioverter Defibrillator (Manual External Defibrillator, Automated External Defibrillator, Wearable External Defibrillator)], End-User (Hospitals, Ambulatory Surgical Center and Others) - Global Opportunity Analysis and Industry Forecast To 2022.
Most sudden cardiac arrest episodes are instigated by the rapid or chaotic activity of the heart known as ventricular tachycardia (VT) or ventricular fibrillation (VF). Cardiac arrest is rescindable in most victims if it's treated within minutes, but the only effective treatment is the delivery of an electrical tremor. With the development of hospital coronary care units, it was found that electrical devices that shocked the heart could turn an abnormally rapid rhythm into a normal one. To achieve this, cardioverter defibrillators have emerged as an effective prevention & treatment measure for enhanced disease management of patients at a higher risk of challenging sudden cardiac arrest across the globe.
The global cardioverter defibrillator devices market is expected to grow at a CAGR of 4.6% from 2017 to 2022 to reach USD 12,520 million by 2022. Growing need for the devices that are faster, effective, and safer is growing rapidly, which is majorly fueling the growth of the market. Technological advancements, increasing number of cardiac patients, and diagnosis and treatment using non-invasive techniques are some of the major factors driving the growth of the market. However, recurrent product recalls hinders the growth of this market to some extent.
The report gives an extensive outlook of global cardioverter defibrillator devices market and carries out an impact analysis of the key industry drivers, restraints, and opportunities analyzed in the market insights segment. Increasing burden of cardiovascular diseases, rising aging population, various technological advancements, and increasing sedentary lifestyle and obesity along with excessive consumption of alcohol & caffeinated products are the key market drivers which will support the industry growth during the forecast period.
The global cardioverter defibrillator devices market report offers an extensive outlook on various segments of the market. This market is majorly segmented by product type [Implantable cardioverter defibrillator (transvenous cardioverter defibrillator, subcutaneous cardioverter defibrillator), external cardioverter defibrillator (manual external defibrillator, automated external defibrillator, wearable external defibrillator)], end-user (hospitals, ambulatory surgical center and others), and geography (North America, Europe, Asia-Pacific, Latin America, Middle East and Africa). The report gives an extensive detail on each of these segment and sub-segment with brief talks about the dynamics, trends impacting the growth of these markets, the benefits involved with the use of these products to improve overall treatment, regional opportunities, key players, technological investment, end user preferences, and future prospects.
An in-depth analysis of the geographical scenario of the industry provides detailed qualitative and quantitative insights about the five major geographies (North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa) along with the coverage of major countries in each region. The geographic analysis provides detailed insights on the key trends of the industry in the listed regions & countries, identifying the demographic & economic impact, government & private investments, and regulatory scenario. The report identifies North America to be the largest market followed by Europe, Asia Pacific, and Rest of World. The geographic analysis section also comments on the key market players shaping the growth of the industry in the respective countries.
The report also includes the industry market share analysis by leading players. The cardioverter defibrillator devices market is highly competitive and consolidated with the top three-four players holding the major share of the market. Medtronic PLC, Abbott Laboratories, and Boston Scientific Corporation are the key players in implantable cardioverter defibrillators market, whereas; Koninklijke Philips N.V., Cardiac Science Corporation, and Zoll Medical Corporation are leading the external defibrillators market. The study has also incorporated the competitive landscape based on extensive assessment of the key strategic developments adopted by leading market participants in the industry over the past 4 years (2014-2017) and detailed profiles of top 13 market players across the value chain of the industry, including detailed financial performance, product offerings, and strategic growth initiatives of each player.
The key players operating in the global cardioverter defibrillator devices market are Medtronic PLC (Ireland), Abbott Laboratories (U.S.), Boston Scientific Corporation (U.S.), BIOTRONIK SE & Co. KG (Germany), LivaNova PLC (U.K.), Stryker Corporation (U.S.), Koninklijke Philips N.V. (Netherlands), Cardiac Science corporation (U.S.), Zoll medical corporation (U.S.), Nihon Kohden Corporation (Japan), Progetti Srl (Italy), Fukuda Denshi Co. (Japan), and Schiller AG (Switzerland).